(LPTX) –
-
Form SC 13G LEAP THERAPEUTICS, INC. Filed by: GILEAD SCIENCES, INC.
-
Form 3 LEAP THERAPEUTICS, INC. For: Apr 10 Filed by: GILEAD SCIENCES, INC.
-
Form 8-K LEAP THERAPEUTICS, INC. For: Apr 10
-
Leap Therapeutics (LPTX) Prices 12.66M Share Private Placement at $2.82/sh
-
Leap Therapeutics Announces $40 Million Private Placement
-
Leap Therapeutics (LPTX) PT Lowered to $9 at Baird
-
Leap Therapeutics (LPTX) PT Lowered to $15 at Piper Sandler
-
Form S-3 LEAP THERAPEUTICS, INC.
-
Form 8-K LEAP THERAPEUTICS, INC. For: Mar 18
-
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
Form 10-K LEAP THERAPEUTICS, INC. For: Dec 31
-
Form SC 13G/A LEAP THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Mashiach Nissim
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Schilsky Richard
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Dietz Thomas John
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Richard Christian M
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Granfield Christine
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Baum Jason
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: O'Mahony John Mark
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Martin Patricia A.
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Sirard Cynthia
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: LOSCALZO JOSEPH
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: LAWLOR AUGUSTINE
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: ONSI DOUGLAS E
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: Mirabelli Christopher
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: LI WILLIAM
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 29 Filed by: CAVANAUGH JAMES H
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 26 Filed by: Mirabelli Christopher
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 26 Filed by: O'Mahony John Mark
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 26 Filed by: Sirard Cynthia
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 26 Filed by: LAWLOR AUGUSTINE
-
Form 4 LEAP THERAPEUTICS, INC. For: Jan 26 Filed by: ONSI DOUGLAS E
-
Form S-8 LEAP THERAPEUTICS, INC.
-
Form 8-K LEAP THERAPEUTICS, INC. For: Jan 23
-
Form 8-K LEAP THERAPEUTICS, INC. For: Jan 16
-
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
-
Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
-
Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
-
Form 8-K LEAP THERAPEUTICS, INC. For: Dec 12
-
Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
-
Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
-
Leap Therapeutics (LPTX) PT Lowered to $12 at Mizuho Securities
-
Leap Therapeutics (LPTX) PT Lowered to $11 at Baird
-
Form 8-K LEAP THERAPEUTICS, INC. For: Nov 13
-
Leap Therapeutics Reports Third Quarter 2023 Financial Results
-
Form 10-Q LEAP THERAPEUTICS, INC. For: Sep 30
-
Form 8-K LEAP THERAPEUTICS, INC. For: Sep 13
-
Leap Therapeutics to Participate at Upcoming Investor Conferences
-
Form S-8 LEAP THERAPEUTICS, INC.
-
Form 4 LEAP THERAPEUTICS, INC. For: Aug 23 Filed by: Dietz Thomas John
Back to LPTX Stock Lookup